Seoul, South Korea

Eunyong Lee

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Cj Cheiljedang Corporation. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eunyong Lee: Innovator in Flavor Modulation and Skin Improvement

Introduction

Eunyong Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of flavor modulation and skin improvement through his innovative patents. With a total of 2 patents, Lee continues to push the boundaries of scientific research and application.

Latest Patents

One of Eunyong Lee's latest patents is focused on peptide compounds for flavor modulation. This invention includes a fermented apple composition that has been shown to reduce or inhibit UV-induced collagenase expression. The implications of this patent extend to skin improvement and the prevention or inhibition of skin photoaging, showcasing Lee's commitment to enhancing both flavor and health.

Career Highlights

Eunyong Lee is currently employed at CJ CheilJedang Corporation, a leading company in the food and biotechnology sectors. His work at this organization allows him to collaborate with other talented professionals and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Eunyong Lee has worked alongside notable colleagues such as Kyung Chan Jeon and Verena Karolin Mittermeier Klessinger. These collaborations have further enriched his research and innovation efforts.

Conclusion

Eunyong Lee stands out as an influential inventor in the realms of flavor modulation and skin health. His innovative patents and contributions to CJ CheilJedang Corporation highlight his dedication to advancing science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…